Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spersadex versus Isopto-Dex for non-infectious conjunctivitis
2004-002887-41Phase 2Completed
- Sponsor
- OmniVision
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of HiDex and dexamethasone in conjunctivitis (2 arms), sponsored by OmniVision. Primary endpoints: Symptom freedom and Change in summed subjective symptom score. Started Nov 2004; status: completed.
02
Drugs
HiDexdexamethasone
03
Conditions
conjunctivitis
Beyond the preview
Go deeper on 2004-002887-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002887-41.